Bargiela, A., Sabater-Arcis, M., Espinosa-Espinosa, J., Zulaica, M., Lopez de Munain, A., & Artero, R. (2019). Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models. Proc Natl Acad Sci U S A.

Bargiela, Ariadna, Maria Sabater-Arcis, Jorge Espinosa-Espinosa, Miren Zulaica, Adolfo Lopez de Munain, and Ruben Artero. "Increased Muscleblind Levels By Chloroquine Treatment Improve Myotonic Dystrophy Type 1 Phenotypes in in Vitro and in Vivo Models." Proc Natl Acad Sci U S A 2019.

Bargiela, Ariadna, et al. "Increased Muscleblind Levels By Chloroquine Treatment Improve Myotonic Dystrophy Type 1 Phenotypes in in Vitro and in Vivo Models." Proc Natl Acad Sci U S A 2019.